Cargando…

Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients

BACKGROUND: To date, reports addressing the antibody response following mRNA SARS-CoV-2 vaccination in lung transplant (LTX) recipients are limited. Thus, the aim of this clinical study was to investigate the efficacy and safety of the vaccines in LTX recipients compared to controls. METHODS: An ope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirama, Takashi, Akiba, Miki, Shundo, Yuki, Watanabe, Tatsuaki, Watanabe, Yui, Oishi, Hisashi, Niikawa, Hiromichi, Okada, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110371/ https://www.ncbi.nlm.nih.gov/pubmed/35599079 http://dx.doi.org/10.1016/j.jiac.2022.04.019

Ejemplares similares

The fraction of sensitization among lung transplant recipients in a transplant center in Japan
por: Kumata, Sakiko, et al.
Publicado: (2020)

Waiting time and mortality rate on lung transplant candidates in Japan: a single-center retrospective cohort study
por: Hirama, Takashi, et al.
Publicado: (2021)

Recovery of physical function in lung transplant recipients with sarcopenia
por: Nikkuni, Etsuhiro, et al.
Publicado: (2021)

Changes in haemodynamics during single lung transplantation under venovenous extracorporeal membrane oxygenation
por: Oishi, Hisashi, et al.
Publicado: (2022)

Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis
por: Hirama, Takashi, et al.
Publicado: (2021)

Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan
por: Ui, Masahiro, et al.
Publicado: (2023)

Ex vivo lung CT findings may predict the outcome of the early phase after lung transplantation
por: Oishi, Hisashi, et al.
Publicado: (2020)

Impact of Postoperative Continuous Renal Replacement Therapy in Lung Transplant Recipients
por: Katahira, Masato, et al.
Publicado: (2020)

Effect of CTLA4-Ig on Obliterative Bronchiolitis in a Mouse Intrapulmonary Tracheal Transplantation Model
por: Suzuki, Yamato, et al.
Publicado: (2021)

Roles of respirologists in lung transplantation in Japan: narrative review
por: Hirama, Takashi, et al.
Publicado: (2023)

A Case of Esophageal Cancer Treated by Thoracoscopic Esophagectomy after Bilateral Cadaveric Lung Transplantation
por: Fukutomi, Toshiaki, et al.
Publicado: (2022)

Impact of intraoperative use of venovenous extracorporeal membrane oxygenation on the status of von Willebrand factor large multimers during single lung transplantation
por: Oishi, Hisashi, et al.
Publicado: (2023)

Correlation between the native lung volume change and postoperative pulmonary function after single lung transplantation for lymphangioleiomyomatosis: Evaluation of lung volume by three-dimensional computed tomography volumetry
por: Suzuki, Hirotoshi, et al.
Publicado: (2019)

Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022)

Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients
por: Kikuchi, Masafumi, et al.
Publicado: (2018)

(651) Long-Term Safety and Efficacy of Mrna Sars-Cov2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2023)

Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022
por: Oishi, Hisashi, et al.
Publicado: (2023)

Perioperative management of esophagectomy in a patient who previously underwent bilateral lung transplantation
por: Toyama, Hiroaki, et al.
Publicado: (2016)

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients
por: Kawabe, Mayuko, et al.
Publicado: (2023)

Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Ślizień, Zuzanna, et al.
Publicado: (2022)

Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection
por: Goda, Yasufumi, et al.
Publicado: (2022)

Antibody response to double SARS-CoV-2 mRNA vaccination in Japanese kidney transplant recipients
por: Fujieda, Kumiko, et al.
Publicado: (2022)

Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor
por: Verma, Mohit K, et al.
Publicado: (2013)

Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients
por: Ohki, Yutaro, et al.
Publicado: (2022)

Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021)

Aortogenic embolic stroke after sleeve pneumonectomy with median sternotomy for lung cancer: a case report
por: Suzuki, Hirotoshi, et al.
Publicado: (2021)

A case report of Indium lung with progressive emphysema and fibrosis underwent lung unilateral transplantation 20 years after the end of the exposure
por: Inoue, Chihiro, et al.
Publicado: (2023)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients
por: Crane, Clarkson, et al.
Publicado: (2021)

Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients
por: Kermond, Rachael F., et al.
Publicado: (2022)

Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
por: Hiraishi, Itaru, et al.
Publicado: (2021)

Correction to: mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

463. Immunogenicity and Safety of mRNA-based SARS-CoV-2 vaccination in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review
por: Cardenas-Alvarez, Jorge Luis, et al.
Publicado: (2023)

Dendriform pulmonary ossification: unusual cause of spontaneous pneumothorax
por: Abe, Jiro, et al.
Publicado: (2014)

Attenuated humoral response against SARS‐CoV‐2 mRNA vaccination in allogeneic stem cell transplantation recipients
por: Toya, Takashi, et al.
Publicado: (2022)

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients
por: Boyarsky, Brian J., et al.
Publicado: (2021)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

CMV Infection Following mRNA SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
por: Chakravorty, Shourjo, et al.
Publicado: (2022)

Collapsing Glomerulonephritis in a Kidney Transplant Recipient after mRNA SARS-CoV-2 Vaccination
por: Gómez Preciado, Francisco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i8hl5kreskdfj2d87i3320kj2l